Table 1. Animal Models of HD.
Model | Construct/Promoter | PolyQ Length | Age of Onset | Pathology | Behavioral Phenotype | Year |
Mouse R6/1 | Human Htt promoter; ~1.9kb fragment of 5´ human HD gene | 115 | 5 m | Intranuclear and neuropil aggregates throughout the brain; global brain atrophy; minimal cell death | Tremors and gait abnormalities; rotarod deficit; clasping behavior; learning deficit | 1996 [23] |
R6/2 | 144 | 2 m | ||||
Drosophila | GAL4-UAS system- using eye-specific P element expression vector pGMR; human HD exon 1 | 75 or 120 | 2 or 10 days | Late-onset progressive neurodegeneration dependent on repeat length; nuclear accumulation but no inclusions | Expression restricted to eyes | 1998 [19] |
Zebrafish | Expanded N-terminal fragment of Htt protein fused with GFP | 102 | 24 h post fertilization | Increase in apoptotic cells, inclusions in non-apoptotic cells | Increase in embryonic lethality or in embryos with abnormal morphology | 1998 [134] |
Mouse N171-82Q | N-terminal 171 amino acids of human Htt; mouse prion promoter | 82 | 5 m | Inclusions in striatum, cortex, hippocampus and amygdala; striatal degeneration | Tremors and gait abnormalities; rotarod deficit; loss of coordination; hypokinesis | 1999 [135] |
Conditional mouse | TetO regulatable; Chimeric mouse/human exon 1. Replace the endogenous | 94 | 4.5 m | Nuclear/ cytoplasmic aggregates in striatum, cortex, and hippocampus; striatal degeneration; gliosis | Clasping behavior, tremor, decreased grooming | 2000 [60] |
Mouse Hdh Q150 | polyQ with expanded polyQ; mouse Hdh promoter | 150 | 4 m | Nuclear inclusions in striatum; striatal gliosis | Clasping behavior; gait abnormalities; rotarod deficit; hypoactivity | 2001 [136] |
Mouse YAC 128 | YAC expressing full-length human Htt; human HD promoter | 128 | 3 m | Inclusions in striatum; neuron loss in striatum | Rotarod deficit; clasping; gait abnormalities; circling behavior | 2003 [137] |
Mouse Hdh Q140 | Replace mouse Htt exon 1 with expanded chimeric mouse/ human exon 1; mouse Hdh promoter | 140 | 12 m | Nuclear and neuropil inclusions in striatum, cortex, nucleus accumbens, and olfactory tubercle | Increased locomotor activity and rearing at 1 month, followed by hypoactivity and gait abnormalities | 2003 [138] |
Transgenic Rat | A truncated Htt fragment; endogenous rat promoter | 51 | Adult onset | Neurological phenotypes, intracellular inclusions, striatal shrinkage | Progressive motor dysfunction | 2003 [139] |
Mouse BAC-HD | Full-length human Htt; human HD promoter | 97 | 3 m | Synaptic dysfunction; cortical and striatal atrophy | Rotarod deficit | 2008 [140] |
Rhesus Macaque Monkey | Human HD exon 1 fused to GFP; Human polyubiquitin-C promoter | 84 | Birth to 1 week | Neuronal inclusions | Dystonia, chorea | 2008 [141] |
Rat BACHD | Human full-length HD genomic sequence; human HD promoter | 97 | Early onset | Cortical and striatal aggregates; neuropil aggregates appear earlier than inclusions; reduced dopamine receptor binding was detectable by in vivo imaging | Robust, early onset and progressive motor deficits and anxiety-related symptoms | 2012 [142] |
HD, human huntingtin gene; Hdh, mouse huntingtin gene; m, months of age; GAL4-UAS system, Transgenic flies expressing GAL4, a yeast transcriptional activator, are crossed with UAS-transgenic flies, carrying a gene of interest inserted downstream of the UAS (upstream activating sequence); YAC, yeast artificial chromosome; BAC, bacteria artificial chromosome; GFP, green fluorescent protein